Lv5
1600 积分 2022-04-20 加入
The regulatory role of CDK4/6 inhibitors in tumor immunity and the potential value of tumor immunotherapy (Review)
7个月前
已完结
An immunological mechanism of resistance to CDK4/6 inhibitors in HR(+) breast cancer
7个月前
已完结
Phosphatidylserine Synthase PTDSS1 Shapes the Tumor Lipidome to Maintain Tumor-Promoting Inflammation
7个月前
已完结
Dual inhibition of AXL and MER kinase: scope for lung and breast cancer therapeutics
7个月前
已完结
Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironment
7个月前
已完结
EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer
7个月前
已完结
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
7个月前
已完结
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies
7个月前
已完结
ALOX15B-based efferocytosis clusters: prognostic implications and immune cell infiltration in breast cancer
7个月前
已完结
RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer
7个月前
已完结
皖公网安备34019202002308
